# Maternal Serum Markers Predicting Preeclampsia At Early Gestations

> **NCT05131282** · — · COMPLETED · sponsor: **HBI Solutions Inc.** · enrollment: 18000 (actual)

## Conditions studied

- Pre-eclampsia
- Preterm Birth

## Interventions

- **DIAGNOSTIC_TEST:** Blood test of PE risk
- **DIAGNOSTIC_TEST:** Blood test of Preterm PE risk

## Key facts

- **NCT ID:** NCT05131282
- **Lead sponsor:** HBI Solutions Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 18000 (ACTUAL)
- **Last updated:** 2024-11-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05131282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05131282, "Maternal Serum Markers Predicting Preeclampsia At Early Gestations". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05131282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*